SCHEMBL1129962

SCHEMBL1129962

CCCCC[C@H](NC(=O)Cc1c[nH]c2ccccc12)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY14 Q15391 1/20 0.53
ALOX15 P16050 1/20 0.53
KCNA5 P22460 1/20 0.52
MMP2 P08253 2/20 0.52
MMP9 P14780 2/20 0.52
MMP8 P22894 2/20 0.52
ACE P12821 4/20 0.52
MTNR1A P48039 2/20 0.52
POLB P06746 2/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
HTT P42858 1/20 0.52
P4HB P07237 1/20 0.52
TP53 P04637 1/20 0.51
C3AR1 Q16581 1/20 0.51
ERAP2 Q6P179 1/20 0.50
ERAP1 Q9NZ08 1/20 0.50
LNPEP Q9UIQ6 1/20 0.50
ITGB2 P05107 1/20 0.50
ICAM1 P05362 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4745190 0.97 P2RY14 (0.54) P2RY14ALOX15KCNA5MMP2MMP9
SCHEMBL6791691 0.89 CCKAR (0.51) P2RY14ALOX15KCNA5MMP2MMP9
SCHEMBL3344871 0.89 MC4R (0.55) P2RY14ALOX15ACEP4HBERAP2
SCHEMBL7271569 0.89 MC4R (0.55) P2RY14ALOX15ACEP4HBERAP2
SCHEMBL17848778 0.85 ACE (0.54) P2RY14ALOX15ACEPOLBMEN1
SCHEMBL5805740 0.85 ACE (0.54) P2RY14ALOX15ACEPOLBMEN1
SCHEMBL3728145 0.83 ALOX15 (0.70) P2RY14ALOX15ACEPOLBMEN1
SCHEMBL13278205 0.83 ALOX15 (0.70) P2RY14ALOX15ACEPOLBMEN1
SCHEMBL6138173 0.83 P2RY14 (0.56) P2RY14ALOX15ACEPOLBMEN1
SCHEMBL29987387 0.83 ALOX15 (0.70) P2RY14ALOX15ACEPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282735-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME Signum Biosciences, Inc. (US) 2011-02-16 EP claimed
WO-2009132051-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME SIGNUM BIOSCIENCES, INC. (US) 2009-10-29 WO claimed
US-10583119-B2 Compounds, compositions and methods for making the same SIGNUM BIOSCIENCES, INC. (US) 2020-03-10 US disclosed
US-20170266161-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME SIGNUM BIOSCIENCES, INC. (US) 2017-09-21 US disclosed
US-9486441-B2 Compounds, compositions and methods for making the same SIGNUM BIOSCIENCES, INC. (US) 2016-11-08 US disclosed
EP-2282735-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME Signum Biosciences, Inc. (US) 2011-02-16 EP disclosed
WO-2009132051-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME SIGNUM BIOSCIENCES, INC. (US) 2009-10-29 WO disclosed
US-20090264496-A1 Compounds, Compositions and Methods for Making the Same SIGNUM BIOSCIENCES, INC. 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264496-A1 Compounds, Compositions and Methods for Making the Same PPP2CA, PPP4C, PPP6C P2RY14 4256/4885ALOX15 4125/4885KCNA5 3842/4885
US-20170266161-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME PPP2CA, PPP4C, PPP6C P2RY14 4256/4885ALOX15 4125/4885KCNA5 3842/4885
US-10583119-B2 Compounds, compositions and methods for making the same PPP2CA, PPP4C, PPP6C P2RY14 4256/4885ALOX15 4125/4885KCNA5 3842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.